Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fibrinogen Concentrate as Initial Treatment for Postpartum Haemorrhage - A Randomised Clinically Controlled Trial

NCT01359878 is registered in ClinicalTrials.gov with Copenhagen University Hospital at Herlev as lead sponsor.

NCT NCT01359878
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01359878 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fibrinogen Concentrate as Initial Treatment for Postpartum Haemorrhage - A Randomised Clinically Controlled Trial
Lead sponsor
Copenhagen University Hospital at Herlev
Phase
Phase 2/3
Overall status
Completed
Start date
May 31, 2011
Completion date
July 31, 2013
Enrollment
249 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

postpartum haemorrhage